Hot Button Issues for Drug and Medical Device Products Liability in 2015

NEW YORK - Nov. 10, 2014 - PRLog -- New to this year’s Drug and Medical Device Litigation conference agenda - prepare for increased off-label, consumer fraud, and false claims enforcement actions stemming from drug and med device products liability.

Record number of attendees registered for this year’s completely refreshed program – December 8-10, Marriott Marquis in New York City.

For more details, visit http://www.drugandmed.com/

►Enforcers’ Spotlight: Understanding Government’s Enforcement Priorities vis-à-vis Drug and Device Products Liability Matters featuring direct DOJ insights.

Even the most seasoned drug and med litigators will benefit from this year's updated agenda and expert insights into the current legal battlefield surrounding products liability litigation:

- Update on the Actos litigation: coordinating discovery and litigation holds, Rule 37(e) changes, and due process arguments

- Insights into FDA’s current position on generic preemption and update on Supreme Court’s grant of cert in Teva Pharmaceuticals USA Inc. v. Superior Court of California

- Practical steps for life sciences companies faced with State AG actions

- Developing appropriate, risk-based protocols for life sciences companies’ social media presence

About ACI - American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.

Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.